Results 201 to 210 of about 36,527 (232)
Some of the next articles are maybe not open access.
Blood
Amyloidosis, also known as light chain amyloidosis (AL), is one of the most common types of systemic amyloidosis affecting patients of older ages with a median age of 64 years. Nearly 4000 new cases are diagnosed annually in the US alone (Dima et. al. JCO Oncology Practice 2023).
Yahan Zhang +5 more
openaire +1 more source
Amyloidosis, also known as light chain amyloidosis (AL), is one of the most common types of systemic amyloidosis affecting patients of older ages with a median age of 64 years. Nearly 4000 new cases are diagnosed annually in the US alone (Dima et. al. JCO Oncology Practice 2023).
Yahan Zhang +5 more
openaire +1 more source
International Journal of Molecular Sciences
A hallmark of type 2 diabetes mellitus (T2DM) is the presence of abundant amyloid deposits composed of amyloid polypeptide (amylin) within the pancreatic islets of Langerhans.
Gourav Shome +5 more
semanticscholar +1 more source
A hallmark of type 2 diabetes mellitus (T2DM) is the presence of abundant amyloid deposits composed of amyloid polypeptide (amylin) within the pancreatic islets of Langerhans.
Gourav Shome +5 more
semanticscholar +1 more source
Seminars in Respiratory and Critical Care Medicine
Amyloidosis is a heterogeneous group of rare diseases characterized by the deposition of misfolded and insoluble proteins in tissues. Lung involvement, airways or parenchyma, is relatively common, but usually mild.
S. Levra, Marcel Opitz, F. Bonella
semanticscholar +1 more source
Amyloidosis is a heterogeneous group of rare diseases characterized by the deposition of misfolded and insoluble proteins in tissues. Lung involvement, airways or parenchyma, is relatively common, but usually mild.
S. Levra, Marcel Opitz, F. Bonella
semanticscholar +1 more source
Blood
Systemic AL amyloidosis is a rare disease caused by the abnormal extracellular deposition of misfolded immunoglobulin light chain fibrils that lead to organ dysfunction and failure.
Ourania Theologi +16 more
semanticscholar +1 more source
Systemic AL amyloidosis is a rare disease caused by the abnormal extracellular deposition of misfolded immunoglobulin light chain fibrils that lead to organ dysfunction and failure.
Ourania Theologi +16 more
semanticscholar +1 more source
MAPK pathway-driven metabolic-inflammatory axis in AL amyloidosis
BloodIntroduction Systemic light chain (AL) amyloidosis is a clonal plasma cell disorder characterized by the deposition of misfolded immunoglobulin light chains in vital organs, often resulting in irreversible organ damage.
Tal Zvida-Bloch +13 more
semanticscholar +1 more source
Blood
Background and aims: In light chain (AL), the circulating immunoglobulin light chains (LCs) have been suggested to provoke cardiotoxicity. We aimed to characterize the underlying mechanisms of LC-mediated cardiotoxicity in vivo to identify novel ...
P. Nikolaou +9 more
semanticscholar +1 more source
Background and aims: In light chain (AL), the circulating immunoglobulin light chains (LCs) have been suggested to provoke cardiotoxicity. We aimed to characterize the underlying mechanisms of LC-mediated cardiotoxicity in vivo to identify novel ...
P. Nikolaou +9 more
semanticscholar +1 more source
European Heart Journal
Light chain amyloidosis (AL), is a plasma cell dyscrasia in which cardiac involvement determines the prognosis. Immunoglobulin light chains (LCs) have been suggested to provoke cardiotoxicity.
P. Nikolaou +14 more
semanticscholar +1 more source
Light chain amyloidosis (AL), is a plasma cell dyscrasia in which cardiac involvement determines the prognosis. Immunoglobulin light chains (LCs) have been suggested to provoke cardiotoxicity.
P. Nikolaou +14 more
semanticscholar +1 more source
Ferroptosis: mechanisms, biology and role in disease
Nature Reviews Molecular Cell Biology, 2021Xuejun Jiang +2 more
exaly
Photodynamic therapy of cancer: An update
Ca-A Cancer Journal for Clinicians, 2011Patrizia M Agostinis +2 more
exaly